ADXN · Addex Therapeutics Ltd. · Holdings
Market Cap
$3.65M
Shares
1.27M
Volume · Oct 6
911
Avg daily vol (3M)
184K
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
Holders: 2
Total Value: $272
Total Shares: 48
Institutional Ownership Trend
26 quarters
Holder Concentration
Across 2 13F filers · Δ vs Mar 31, 2026Top Holder
98.2%
+32.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
9,639
Highly concentrated+4,692
Quarterly Activity
vs Mar 31, 2026
New
1
Increased
0
Decreased
0
Sold Out
3
Unchanged
1
Holder count:
-2
Institutional value:
-90.5%
Shares held:
-89.5%
Top New Positions
vs Mar 31, 2026| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| Mega UBS Group AG | 47 | $267 |
Top Sold-Out Positions
vs Mar 31, 2026| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mega MORGAN STANLEY | 301 | $1,893 | |
| Mid GAMMA Investing LLC | 81 | $509 | |
| Mega RHUMBLINE ADVISERS | 72 | $452 |
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Mega UBS Group AG | $267 | 98.16% | 47 | Shares | 2026-08-13 | |
| Mid SBI Securities Co., Ltd. Broker-Dealer | $5 | 1.84% | 1 | Shares | 2026-07-23 |